What is the recommended use of Nephro HP (renal-specific protein supplement) as oral feeding for a 73-year-old female patient with end-stage renal disease (ESRD) due to diabetes, sepsis from pneumonia, and undergoing hemodialysis, weighing 45 kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Use of Nephro HP for Oral Nutritional Support in a 73-Year-Old Female with ESRD on Hemodialysis

Nephro HP or similar renal-specific high-protein oral nutritional supplements should be used in this patient to achieve the target protein intake of 1.2 g/kg/day (54 g/day for 45 kg), given her critical illness with sepsis, ongoing hemodialysis, and likely inadequate oral intake. 1, 2

Protein Requirements in This Clinical Context

  • Target protein intake is 1.2 g/kg/day for stable hemodialysis patients, which equals approximately 54 grams daily for this 45 kg patient. 1, 2
  • In the setting of acute sepsis and critical illness, protein requirements may increase to 1.2-1.5 g/kg/day to offset catabolism and promote tissue repair. 3
  • At least 50% of protein should come from high biological value sources (animal proteins, whey, egg albumin). 1, 2
  • Each hemodialysis session removes approximately 10-12 g of amino acids, creating substantial ongoing losses that must be replaced. 2

Energy Requirements

  • Target energy intake is 30-35 kcal/kg/day for patients ≥60 years old, which translates to 1,350-1,575 kcal/day for this 45 kg patient. 2, 3
  • Adequate energy intake is essential to maintain neutral nitrogen balance and prevent protein from being catabolized for energy. 2

Oral Nutritional Supplement Strategy

Oral nutritional supplements (ONS) should be the preferred first-line approach in conscious hemodialysis patients with poor oral intake before considering more invasive options. 1, 4

Timing and Administration:

  • ONS should be given 2-3 hours after usual meals to avoid nutritional substitution and suppression of regular food intake. 4
  • Late evening ONS can help reduce overnight catabolism without reducing normal food consumption during the day. 4
  • Intradialytic delivery of ONS has been associated with better compliance and should be considered during her thrice-weekly hemodialysis sessions. 4

Formula Selection:

  • Hemodialysis-specific formulas (like Nephro HP) should be preferred for tube feeding, while standard ONS can be used for oral supplementation. 4
  • Renal-specific formulas typically have higher protein content and lower electrolyte content (particularly potassium and phosphorus) to achieve protein targets while minimizing fluid overload. 3

Escalation Pathway if Oral Intake Remains Inadequate

Before considering nutrition support, ensure any potentially reversible conditions affecting appetite have been addressed (uremic toxicity, medication side effects, depression, inadequate dialysis). 1

Step-wise approach:

  1. Dietary counseling and education should be the first intervention. 1
  2. If oral intake including ONS remains inadequate after counseling, consider tube feeding if medically appropriate. 1
  3. If tube feeding is not feasible, intradialytic parenteral nutrition (IDPN) should be considered for malnourished patients who fail to respond to or cannot tolerate ONS. 1
  4. If the combination of oral intake and IDPN does not meet requirements, daily total or partial parenteral nutrition should be considered. 1

Critical Monitoring Parameters

Given her sepsis and risk of refeeding syndrome, strict monitoring is essential:

  • Monitor plasma electrolytes and phosphorus closely when initiating nutritional support to prevent refeeding syndrome. 3
  • Serum albumin should be monitored every 1-4 months, with a target of maintaining in the normal range. 2
  • Calculate normalized protein nitrogen appearance (nPNA), with a target of ≥0.9 g/kg/day. 2
  • Assess for >10% body weight loss over 6 months and maintain BMI >20 kg/m². 2
  • The dialysis regimen should be regularly monitored and modified to treat any intensification of uremia caused by increased protein intake. 1

Special Considerations for Sepsis and Pneumonia

In the acute septic phase, enteral nutrition should be started at low rates and increased slowly over days to minimize metabolic complications. 3

Protein intake of 1.2-1.3 g/kg/day should be maintained regardless of dialysis status to promote protein synthesis and conserve tissue during critical illness. 3

Micronutrient Supplementation

Water-soluble B vitamins should be supplemented due to dialytic losses:

  • Folic acid: 1 mg/day 2
  • Pyridoxine (B6): 10-20 mg/day 2
  • Thiamine supplementation is particularly important as deficiency is common (24.7% prevalence) in ESRD patients. 5

Common Pitfalls to Avoid

  • Do not restrict protein intake below 1.2 g/kg/day in an attempt to reduce uremia—instead, optimize dialysis adequacy. 1
  • Monitor phosphorus and potassium content carefully when increasing protein intake, as protein-rich foods are major sources of these minerals. 1, 4
  • Avoid overfeeding, particularly with glucose administration exceeding 7 mg/kg/min, which increases risk of hepatic complications. 1
  • Do not delay nutritional intervention—in acutely ill hospitalized patients, inadequate intake for even days to 2 weeks can worsen outcomes depending on baseline nutritional status. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Amino Acid Supplementation in Dialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Nutritional Support for Septic Patients with CKD Stage V

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Dietary Guidelines for Patients with Severe Gastroparesis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.